1-3 of 3
Anna L Godfrey, BMBCh, PhD
Close
Sort by
Journal Articles

Effects of Tamoxifen on the Mutant Allele Burden and Disease Course in Patients with Myeloproliferative Neoplasms - Results of the Tamarin Study

Claire Harrison, DM, FRCP, FRCPath, Joanna Baxter, PhD, Rebecca H. Boucher, BSc, MSc, PhD, Thomas McKerrell, MD PhD, Aimee Jackson, BSc, MSc, Rachel S Fletcher, PhD, Adam J. Mead, MD PhD, Steve Knapper, BMBCh, MRCP, FRCPath, DM, Joanne Ewing, MD PhD, Nauman M Butt, MD, Manish Jain, MBBS, MRCP, FRCpath, Sebastian Francis, MBChB, FRCPath, MD, Fiona J Clark, FRCP, FRCPath, Jason Coppell, MBBS, Mary Frances McMullin, MDFRCP, FRCPath, Frances Wadelin, MB ChB, PhD FRCPath, Srinivasan Narayanan, FRCP, FRCPath, Dragana Milojkovic, Mark W. Drummond, PhD FRCPath, Mallika Sekhar, MBBS, MD, Maike Paramor, James Roberts, BSc, Rachel Glover, BSc, Erica Harris, MSc, Luigi Grassi, PhD, Alba Rodriguez-Meira, PhD, Jason Carroll, PhD FMedSci, José-Ezequiel Martín, PhD, Giuditta Corbizi Fattori, PhD, Zijian Fang, BSc, Anna L Godfrey, BMBCh, PhD, Simón Méndez-Ferrer, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–35.
https://doi.org/10.1182/blood-2020-134764
Published: 2020
Journal Articles

Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial

Anna L. Godfrey, BMBCh, PhD MRCP, FRCPath, Peter J Campbell, MD PhD, Cathy MacLean, BSc, MSc, MBA, Georgina Buck, BSc, MSc, Clare L. East, BSc, Julia Cook, BSc, Julie Temple, BSc, Bridget S. Wilkins, MD FRCPath, Keith Wheatley, DPhil, Jyoti Nangalia, MBBChir, MA, MRCP, FRCPath, PhD, Jacob Grinfeld, MBChB, BSc, MRCP, FRCPath, Mary Frances Frances McMullin, MB,Bch BAO, MD FRCPath, Cecily Forsyth, MB BS, Jean-Jacques Kiladjian, MD PhD, Anthony R. Green, FRCP, FRCPath, FMed Sci, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 319.
https://doi.org/10.1182/blood.V130.Suppl_1.319.319
Published: 2017
Journal Articles

Personalized Prognostic Predictions for Patients with Myeloproliferative Neoplasms through Integration of Comprehensive Genomic and Clinical Information

Jacob Grinfeld, MBChB, BSc, MRCP, FRCPath, Jyoti Nangalia, MBBChir, MA, MRCP, FRCPath, PhD, E Joanna Baxter, PhD, Anna L. Godfrey, BMBCh, PhD MRCP, FRCPath, Paola Guglielmelli, MD PhD, Rob Cantrill, PhD, David Wedge, PhD, Nicos Angelopoulos, PhD, Gunes Gundem, PhD, Charlie Massie, PhD, Elli Papaemmanuil, PhD, Cathy MacLean, BSc, MSc, MBA, Julia Cook, BSc, Francesca Lauren Nice, PhD MSc, Christen Lykkegaard Andersen, PhD, Hans Carl Hasselbalch, MD Professor, DMSc, Mary Frances McMullin, MB,Bch BAO, MD FRCPath, Alessandro M. Vannucchi, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Moritz Gerstung, PhD, Peter J Campbell, MD PhD, Anthony R Green, PhD FRCP, FRCPath, FMedSci
Journal: Blood
Blood (2017) 130 (Supplement 1): 491.
https://doi.org/10.1182/blood.V130.Suppl_1.491.491
Published: 2017